Literature DB >> 20226413

Hysteroscopic sterilization in patients with a Mirena intrauterine device: transition from extended interval to permanent contraception.

Jennifer M Tatalovich1, Ted L Anderson.   

Abstract

OBJECTIVE: To estimate the feasibility and elucidate the benefits of performing hysteroscopic sterilization in patients who have a Mirena intrauterine device (IUD) in place.
DESIGN: Retrospective case-controlled study with 3:1 ratio (Canadian Task Force Classification II-2).
SETTING: Procedures were performed in an outpatient or office setting affiliated with an academic medical center. Hysterosalpingograms were obtained and interpreted jointly by an investigator and a radiologist using standard protocol. PATIENTS: Subjects included all patients undergoing hysteroscopic sterilization July 2007 thru December 2008 with a Mirena IUD in place. Patients without an IUD served as a comparison group.
INTERVENTIONS: All procedures were performed with a 4.2-mm Bettocchi continuous-flow hysteroscope with saline solution insufflation. Delivery catheters were passed through a 5F operative channel. Essure implants were positioned and released per standard protocol. IUD devices were removed after confirmation of bilateral tubal occlusion. MEASUREMENTS & MAIN
RESULTS: There were 12 patients currently using a Mirena IUD for contraception who elected to undergo hysteroscopic sterilization. Procedures were performed in the usual manner. Chart review identified the most recently treated patients without an IUD in place matched for age and body mass index to study patients. Recorded details included age, body mass index, parity, procedure time, placement success, and tubal occlusion. There were no significant differences between the groups with respect to any metric except completion of the 3- month hysterosalpingogram.
CONCLUSION: Hysteroscopic sterilization can be performed successfully with a Mirena IUD in place. Advantages include flexibility in timing of the procedure, assurance of contraception until confirmation of tubal occlusion, and increased likelihood of appropriate follow-up. Copyright 2010 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20226413     DOI: 10.1016/j.jmig.2009.12.019

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  3 in total

1.  Adherence to hysterosalpingogram appointments following hysteroscopic sterilization among low-income women.

Authors:  Ophra Leyser-Whalen; Abbey B Berenson
Journal:  Contraception       Date:  2013-08-01       Impact factor: 3.375

Review 2.  A Meta-Analysis of Bilateral Essure® Procedural Placement Success Rates on First Attempt.

Authors:  Gabriel Frietze; Ophra Leyser-Whalen; Mahbubur Rahman; Mahta Rouhani; Abbey B Berenson
Journal:  J Gynecol Surg       Date:  2015-12-01

3.  Hysteroscopic sterilization of patient with intrauterine device Mirena®.

Authors:  Daniella De Batista Depes; Ana Maria Gomes Pereira; Salete Yatabe; Reginaldo Guedes Coelho Lopes
Journal:  Einstein (Sao Paulo)       Date:  2013 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.